|
2023 Conference Publication Adding mitomycin (MM) to bacillus Calmette-Guerin (BCG) as adjuvant intravesical therapy for high-risk, non-muscle-invasive urothelial bladder cancer (NMIBC)Hayne, Dickon, Stockler, Martin R., Martin, Andrew James, McCombie, Steve P., Zebic, Danka Sinikovic, Bastick, Patricia A., Beardsley, Emma Kate, Frydenberg, Mark, Green, William, Grummet, Jeremy, Hawks, Cynthia, Ischia, Joseph, Mitterdorfer, Andrew, Patel, Manish, Roberts, Matthew, Sengupta, Shomik, Srivastav, Ratnesh Kumar, Redfern, Andrew David and Davis, Ian D. (2023). Adding mitomycin (MM) to bacillus Calmette-Guerin (BCG) as adjuvant intravesical therapy for high-risk, non-muscle-invasive urothelial bladder cancer (NMIBC). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL USA, 2-6 June 2023. Philadelphia, PA USA: Lippincott Williams & Wilkins. |
|
2023 Journal Article Treatment de‐intensification for low‐risk biochemical recurrence after radical prostatectomy: rational or risky?Roberts, Matthew J., Hruby, George, Kneebone, Andrew, Martin, Jarad M., Williams, Scott G., Frydenberg, Mark, Murphy, Declan G., Namdarian, Ben, Yaxley, John W., Hofman, Michael S., Davis, Ian D. and Emmett, Louise (2023). Treatment de‐intensification for low‐risk biochemical recurrence after radical prostatectomy: rational or risky?. BJU International, 132 (2), 146-148. doi: 10.1111/bju.16086 |
|
2023 Journal Article Synchronous versus independent reading of PSMA‐PET and MRI to improve diagnosis for prostate cancerDoan, Paul, Counter, William, Papa, Nathan, Sheehan‐Dare, Gemma, Ho, Bao, Lee, Jonathan, Liu, Victor, Thompson, James E., Agrawal, Shikha, Roberts, Matthew J., Buteau, James, Hofman, Michael S., Moon, Daniel, Lawrentschuk, Nathan, Murphy, Declan, Stricker, Phillip D. and Emmett, Louise (2023). Synchronous versus independent reading of PSMA‐PET and MRI to improve diagnosis for prostate cancer. BJU International, 131 (5), 588-595. doi: 10.1111/bju.15929 |
|
2023 Journal Article Pubic symphysis septic arthritis due to urosymphyseal fistula: conservative management can workMehawed, Georges, Ranasinghe, Sachinka and Roberts, Matthew J. (2023). Pubic symphysis septic arthritis due to urosymphyseal fistula: conservative management can work. Urology Case Reports, 47 102356, 1-3. doi: 10.1016/j.eucr.2023.102356 |
|
2023 Conference Publication PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancerButeau, James Patrick, Moon, Daniel, Fahey, Michael T., Roberts, Matthew, Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, Kasivisvanathan, Veeru, Stricker, Phillip, O'Brien, Jonathan, Counter, William, Sharma, Gaurav, Agrawal, Shikha, Ho, Bao, Yeung, Theresa, Lourenco, Richard De Abreu, Dhillon, Haryana M., Hofman, Michael S. and Emmett, Louise (2023). PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer. Genitourinary Cancers Symposium, Electr Network, 16-18 February 2023. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2023.41.6_suppl.TPS397 |
|
2023 Conference Publication PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancerButeau, James Patrick, Moon, Daniel, Fahey, Michael T., Roberts, Matthew, Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, Kasivisvanathan, Veeru, Stricker, Phillip, O'Brien, Jonathan, Counter, William, Sharma, Gaurav, Agrawal, Shikha, Ho, Bao, Yeung, Theresa, De Abreu Lourenço, Richard, Dhillon, Haryana M., Hofman, Michael S and Emmett, Louise (2023). PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer. 2023 ASCO Genitourinary Cancers Symposium, San Francisco, CA United States, 16-18 February 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.6_suppl.tps397 |
|
2023 Conference Publication Baseline PSMA PET-CT is prognostic for treatment failure in men with intermediate-to-high risk prostate cancer: 54 months follow-up of the proPSMA randomised trialKasivisvanathan, V., Murphy, D.G., Link, E., Lawrentschuk, N., O’Brien, J., Buteau, J.P., Roberts, M., Francis, R.J., Tang, C., Vela, I., Thomas, P., Rutherford, N., Martin, J., Frydenberg, M., Shakher, R., Wong, L-M., Taubman, K., Lee, S.T., Hsiao, E., Nottage, M., Kirkwood, I., Iravani, A., Williams, S. and Hofman, M.S. (2023). Baseline PSMA PET-CT is prognostic for treatment failure in men with intermediate-to-high risk prostate cancer: 54 months follow-up of the proPSMA randomised trial. EAU23 - 38th Annual EAU Congress, Milan, Italy, 10-13 March 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(23)01275-7 |
|
2023 Journal Article Extracellular vesicles for precision medicine in prostate cancer: is it ready for clinical translation?Robinson, Harley, Roberts, Matthew J., Gardiner, Robert A. and Hill, Michelle M. (2023). Extracellular vesicles for precision medicine in prostate cancer: is it ready for clinical translation?. Seminars in Cancer Biology, 89, 18-29. doi: 10.1016/j.semcancer.2023.01.003 |
|
2023 Journal Article Variation in patient reported outcomes following radical prostatectomy: a bi-national registry-based studyO'Callaghan, Michael E., Roberts, Matthew J., Moretti, Kim L., Frydenberg, Mark, Gilbourd, Daniel, Mark, Stephen, Heathcote, Peter, Millar, Jeremy, PCOR-ANZ and Papa, Nathan (2023). Variation in patient reported outcomes following radical prostatectomy: a bi-national registry-based study. Urologic Oncology: Seminars and Original Investigations, 41 (2), 105.e9-105.e18. doi: 10.1016/j.urolonc.2022.10.020 |
|
2023 Journal Article Plain x‐ray misses many ureteric calculi: Time to challenge the old dogma?McGeorge, Stephen, Loh, Brendon, Shibu, Ryan, Dobeli, Karen, Brown, Nathan J., Esler, Rachel, Hacking, Craig, Purvey, Megan and Roberts, Matthew J. (2023). Plain x‐ray misses many ureteric calculi: Time to challenge the old dogma?. BJUI Compass, 4 (1), 59-61. doi: 10.1002/bco2.192 |
|
2022 Journal Article Using PSMA imaging for prognostication in localized and advanced prostate cancerRoberts, Matthew J., Maurer, Tobias, Perera, Marlon, Eiber, Matthias, Hope, Thomas A., Ost, Piet, Siva, Shankar, Hofman, Michael S., Murphy, Declan G., Emmett, Louise and Fendler, Wolfgang P. (2022). Using PSMA imaging for prognostication in localized and advanced prostate cancer. Nature Reviews Urology, 20 (1), 23-47. doi: 10.1038/s41585-022-00670-6 |
|
2022 Journal Article 68Ga‐PSMA PET / CT false positive liver metastasis prior to radical prostatectomySaad, Jeremy, Shanmugasundaram, Ramesh, Wong, Veronica, Le, Ken, Arianayagam, Mohan and Roberts, Matthew J. (2022). 68Ga‐PSMA PET / CT false positive liver metastasis prior to radical prostatectomy. ANZ Journal of Surgery, 93 (4), 1029-1030. doi: 10.1111/ans.18051 |
|
2022 Conference Publication Genetic testing in prostate cancer: a scoping literature reviewEdmunds, Kim, Arora, Shiksha, Roberts, Matthew, Fairbairn, David, Scuffham, Paul, Smith, David, Chambers, Suzanne, Horvath, Lisa and Tuffaha, Haitham (2022). Genetic testing in prostate cancer: a scoping literature review. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2022 Journal Article The PRIMARY score: using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosisEmmett, Louise M., Papa, Nathan, Buteau, James, Ho, Bao, Liu, Victor, Roberts, Matthew, Thompson, James, Moon, Daniel, Sheehan-Dare, Gemma, Alghazo, Omar, Agrawal, Shikha, Murphy, Declan G., Stricker, Phillip, Hope, Thomas A. and Hofman, Michael (2022). The PRIMARY score: using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosis. Journal of Nuclear Medicine, 63 (11), 1644-1650. doi: 10.2967/jnumed.121.263448 |
|
2022 Journal Article Cellular milieu in clear cell renal cell carcinomaRaghubar, Arti M., Roberts, Matthew J., Wood, Simon, Healy, Helen G., Kassianos, Andrew J. and Mallett, Andrew J. (2022). Cellular milieu in clear cell renal cell carcinoma. Frontiers in Oncology, 12 943583, 1-10. doi: 10.3389/fonc.2022.943583 |
|
2022 Journal Article Testicular torsion: not just in young menSaad, Jeremy, Shanmugasundaram, Ramesh, Heywood, Sean, Varol, Celi and Roberts, Matthew J. (2022). Testicular torsion: not just in young men. Journal of Urological Surgery, 9 (3), 215-217. doi: 10.4274/jus.galenos.2021.2021.0085 |
|
2022 Journal Article Low‐Grade Prostate Cancer Should Still be Labeled CancerIczkowski, Kenneth A., Molina, Mariel, Egevad, Lars, Bostwick, David G., van Leenders, Geert J.L.H., La Rosa, Francisco G., van der Kwast, Theodorus, Berney, Daniel M., Evans, Andrew J., Wheeler, Thomas M., Leite, Katia R.M., Samaratunga, Hemamali, Srigley, John, Varma, Murali, Tsuzuki, Toyonori, Lucia, M. Scott, Crawford, E. David, Harris, Richard G., Stricker, Philip, Lawrentschuk, Nathan, Woo, Henry H., Fleshner, Neil E., Shore, Neal D., Yaxley, John, Bratt, Ola, Wiklund, Peter, Roberts, Matthew, Cheng, Liang and Delahunt, Brett (2022). Low‐Grade Prostate Cancer Should Still be Labeled Cancer. BJU International, 130 (6), 741-743. doi: 10.1111/bju.15886 |
|
2022 Journal Article Mineral content variations between Australian tap and bottled water in the context of urolithiasisKwok, Michael, McGeorge, Stephen, Roberts, Matthew, Somani, Bhaskar and Rukin, Nicholas (2022). Mineral content variations between Australian tap and bottled water in the context of urolithiasis. BJUI Compass, 3 (5), 377-382. doi: 10.1002/bco2.168 |
|
2022 Journal Article Event‐free survival after radical prostatectomy according to PSMA PET and EAU Biochemical Recurrence Risk GroupsRoberts, Matthew J., Chatfield, Mark D., Hruby, George, Nandurkar, Rohan, Roach, Paul, Watts, Jo Anne, Cusick, Thomas, Kneebone, Andrew, Eade, Thomas, Ho, Bao, Nguyen, Andrew, Tang, Colin, McCarthy, Michael, Francis, Roslyn, Stricker, Phillip and Emmett, Louise (2022). Event‐free survival after radical prostatectomy according to PSMA PET and EAU Biochemical Recurrence Risk Groups. BJU International, 130 (S3), 32-39. doi: 10.1111/bju.15762 |
|
2022 Journal Article All Prostate-specific Membrane Antigen Peptides Are Equal, but Some Are More Equal than OthersEmmett, Louise, Pattison, David A. and Roberts, Matthew J. (2022). All Prostate-specific Membrane Antigen Peptides Are Equal, but Some Are More Equal than Others. European urology oncology, 5 (3), 283-284. doi: 10.1016/j.euo.2022.04.002 |
